SERUM-LIPIDS AND THYROTROPIN IN WOMEN WITH CORONARY-ARTERY DISEASE

被引:6
作者
STUBBS, PJ
MULROONEY, BD
COLLINSON, PO
FOWLER, PBS
NOBLE, MIM
机构
[1] CHARING CROSS HOSP, DEPT MED, LONDON W6 8RP, ENGLAND
[2] CHARING CROSS & WESTMINSTER MED SCH, ACAD UNIT CARDIOVASC MED, LONDON, ENGLAND
[3] W MIDDLESEX UNIV HOSP, DEPT CARDIOL, ISLEWORTH, ENGLAND
[4] MAYDAY UNIV HOSP, DEPT CHEM PATHOL, CROYDON, ENGLAND
关键词
THYROTROPIN; CORONARY ARTERY DISEASE; FEMALE; LIPIDS;
D O I
10.1093/oxfordjournals.eurheartj.a060528
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Abnormalities of thyroid function are associated with changes in lipid concentrations and in the incidence of ischaemic heart disease. Whether lipid concentration and thyroid function are related when thyroid function is normal in ischaemic heart disease is uncertain. This study was undertaken to investigate the relationship between thyroid function, serum lipids and ischaemic heart disease in euthyroid women.Forty-six euthyroid patients were studied. Patients with diseases known to affect lipid levels or receiving drugs known to alter lipid or thyroid metabolism were excluded Twenty-three had ischaemic heart disease (IHD) and were matched with 23 controls. Correlations were found between thyrotropin (TSH) and cholesterol (P=0·05) low density lipoprotein (LDL) (P=0·09) and triglyceride (P=0·009 in the IHD group but not between any serum lipids and TSH in the control group. Analysis of covariance showed a statistically significant difference between groups of the association between cholesterol and TSH (P<0·05 (slope) P<0·001 (means)), LDL and TSH (P<0·005 (means)) and between triglyceride and TSH (P<0·05 (means)). This study suggests that TSH within the normal range is having a statistically significant effect on lipid levels in women with ischaemic heart disease. © 1994 The European Society of Cardiology.
引用
收藏
页码:468 / 471
页数:4
相关论文
共 21 条
[1]  
ALAGHBANDZADEH J, 1977, LANCET, V2, P998
[2]   ASYMPTOMATIC HYPOTHYROIDISM AND HYPERCHOLESTEROLEMIA [J].
BALL, MJ ;
GRIFFITHS, D ;
THOROGOOD, M .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1991, 84 (09) :527-529
[3]  
BASCHIERI L, 1975, REV FRANC ENDOCRINOL, V3, P212
[4]  
BASTENIE PA, 1977, LANCET, V2, P155
[5]   L-THYROXINE THERAPY IN SUBCLINICAL HYPOTHYROIDISM - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
COOPER, DS ;
HALPERN, R ;
WOOD, LC ;
LEVIN, AA ;
RIDGWAY, EC .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (01) :18-24
[6]   EXAGGERATED RESPONSIVENESS TO THYROTROPIN RELEASING HORMONE - A RISK FACTOR IN WOMEN WITH CORONARY-ARTERY DISEASE [J].
DEAN, JW ;
FOWLER, PBS .
BRITISH MEDICAL JOURNAL, 1985, 290 (6481) :1555-1561
[7]   THE RELATIONSHIP BETWEEN SERUM-CHOLESTEROL AND SERUM THYROTROPIN, THYROXINE AND TRI-IODOTHYRONINE CONCENTRATIONS IN SUSPECTED HYPOTHYROIDISM [J].
ELDER, J ;
MCLELLAND, A ;
OREILLY, DS ;
PACKARD, CJ ;
SERIES, JJ ;
SHEPHERD, J .
ANNALS OF CLINICAL BIOCHEMISTRY, 1990, 27 :110-113
[8]  
FOWLER PBS, 1970, LANCET, V2, P488
[9]  
FOWLER PBS, 1967, LANCET, V1, P1077
[10]   CHOLESTEROL SCREENING PROGRAMS - HOW MUCH POTENTIAL BENEFIT [J].
KHAW, KT ;
ROSE, G .
BRITISH MEDICAL JOURNAL, 1989, 299 (6699) :606-607